bioSyntagma Company

bioSyntagma develops molecular fingerprint for diagnosing and discovering disease.

Last Funding Type: Grant
Headquarters: Phoenix, Arizona, United States
Founded Date: 2015-04-02
Last Funding Date: 2018-03-19
Total Funding: 1382086
Technology: ['BioTech & HealthTech', 'Education, Research & SocialTech']
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Investors Number: 2
Industry: Aging Biomarkers